Skin biopsies may reveal new insights about long COVID

CND Life Sciences is conducting a clinical study to analyze skin biomarkers that may provide insights into neurological issues associated with long COVID. Arizona residents are invited to participate, contributing to research that seeks to understand potential nerve damage in long COVID patients through skin biopsies. Symptoms of long COVID can include fatigue, joint pain, and various neurological complaints, indicating possible dysfunction in sensory or autonomic nerves. Dr. Todd Levine, chief medical officer of CND, highlights the urgency of this study to uncover important pathological answers for patients.

CND operates a CLIA-certified laboratory and has pioneered the Syn-One Test®, which detects phosphorylated alpha-synuclein in cutaneous nerves. This test improves diagnostic accuracy for diseases like Parkinson’s and may also identify other neuropathologies. With a growing number of long COVID cases in Arizona, the study aims to enhance understanding of these complications and explore innovative treatments. Interested individuals can visit cndlifesciences. com/lccsstudy for more information and enrollment.